+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Cryptococcosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cryptococcosis Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 473 Pages
  • Global
From
Cytomegalovirus (CMV) Treatment - Global Strategic Business Report - Product Thumbnail Image

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 384 Pages
  • Global
From
Infectious Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Infectious Disease Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 385 Pages
  • Global
From
Clostridium Difficile Treatment - Global Strategic Business Report - Product Thumbnail Image

Clostridium Difficile Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 192 Pages
  • Global
From
Rabies Treatment - Global Strategic Business Report - Product Thumbnail Image

Rabies Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 179 Pages
  • Global
From
From
Antivirals Drug - Global Strategic Business Report - Product Thumbnail Image

Antivirals Drug - Global Strategic Business Report

  • Report
  • February 2026
  • 362 Pages
  • Global
From
Alopecia Drugs - Global Strategic Business Report - Product Thumbnail Image

Alopecia Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 187 Pages
  • Global
From
Prescription Drugs - Global Strategic Business Report - Product Thumbnail Image

Prescription Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 269 Pages
  • Global
From
From
From
Anti-Inflammatory Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 488 Pages
  • Global
From
Crohn`s Disease (CD) Therapy - Global Strategic Business Report - Product Thumbnail Image

Crohn`s Disease (CD) Therapy - Global Strategic Business Report

  • Report
  • February 2026
  • 142 Pages
  • Global
From
Autoimmune Drugs - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 287 Pages
  • Global
From
Anti-Inflammatory Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Loading Indicator